Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor
Clinical trial NCT01567085 · COMPLETED
Trial details
- NCT number
- NCT01567085
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-29
- Primary completion
- 2015-06-11
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.